CORD-19:867ebb2be2d466bcb35e5a7319708eaff39c4799 / 87504-87648 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/867ebb2be2d466bcb35e5a7319708eaff39c4799","sourcedb":"CORD-19","sourceid":"867ebb2be2d466bcb35e5a7319708eaff39c4799","text":"The clinical response rate at TOC visit was 81.8% (54/66) in the cefoperazone/sulbactam group, while it was 79.0% (64/81) in the cefepime group.","tracks":[{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T309","span":{"begin":0,"end":144},"obj":"Sentence"}],"attributes":[{"subj":"T309","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-Sentences","denotations":[{"id":"T47736","span":{"begin":0,"end":144},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T47736","pred":"source","obj":"CORD-19-Sentences"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19_Custom_license_subset","color":"#d7ec93","default":true},{"id":"CORD-19-Sentences","color":"#e793ec"}]}]}}